Our Pipeline

Neumora has a broad pipeline of novel medicines for neuropsychiatric disorders and neurodegenerative disorders, each of which will be paired with a proprietary Precision Phenotype™ to ensure a targeted approach to development.

In addition to internally discovered programs, Neumora has partnered with Amgen to pursue additional complementary opportunities and maximize the value we can deliver to patients. Learn more:

News